Literature DB >> 15355756

Recent advances in the treatment of opiate addiction.

Paul J Fudala1, George W Woody.   

Abstract

Although addiction to heroin and other opiates is a major public health issue in the United States and many other countries, advances in pharmacologic and nonpharmacologic treatment have been made. Some of these advances represent a major shift from traditional treatment philosophies, whereas others are characterized by more subtle, though important, improvements. This review discusses recent advances in opiate-addiction treatment in the context of three main domains: the use of buprenorphine and buprenorphine/naloxone in an office-based paradigm, psychosocial treatment and the addressing of medical and psychiatric comorbidity, and harm reduction strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355756     DOI: 10.1007/s11920-004-0020-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  37 in total

1.  Developing a national addiction treatment information system. An introduction to the Drug Evaluation Network System.

Authors:  D Carise; A T McLellan; L S Gifford; H D Kleber
Journal:  J Subst Abuse Treat       Date:  1999 Jul-Sep

2.  A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.

Authors:  Steven L Batki; Valerie A Gruber; Julia Moon Bradley; Mark Bradley; Kevin Delucchi
Journal:  Drug Alcohol Depend       Date:  2002-05-01       Impact factor: 4.492

3.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

4.  Buprenorphine : characteristics of binding sites in the rat central nervous system.

Authors:  J W Villiger; K M Taylor
Journal:  Life Sci       Date:  1981-12-28       Impact factor: 5.037

5.  Needle-exchange attendance and health care utilization promote entry into detoxification.

Authors:  S A Strathdee; D D Celentano; N Shah; C Lyles; V A Stambolis; G Macalino; K Nelson; D Vlahov
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

6.  Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.

Authors:  J Rehm; P Gschwend; T Steffen; F Gutzwiller; A Dobler-Mikola; A Uchtenhagen
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

7.  High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.

Authors:  J Bruneau; F Lamothe; E Franco; N Lachance; M Désy; J Soto; J Vincelette
Journal:  Am J Epidemiol       Date:  1997-12-15       Impact factor: 4.897

8.  Providing medical care to methadone clinic patients: referral vs on-site care.

Authors:  A Umbricht-Schneiter; D H Ginn; K M Pabst; G E Bigelow
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

Review 9.  Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

Review 10.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

View more
  4 in total

1.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

2.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

Authors:  David S Metzger; Deborah Donnell; David D Celentano; J Brooks Jackson; Yiming Shao; Apinun Aramrattana; Liu Wei; Liping Fu; Jun Ma; Gregory M Lucas; Marek Chawarski; Yuhua Ruan; Paul Richardson; Katherine Shin; Ray Y Chen; Jeremy Sugarman; Bonnie J Dye; Scott M Rose; Geetha Beauchamp; David N Burns
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

3.  A pilot assessment of relapse prevention for heroin addicts in a Chinese rehabilitation center.

Authors:  Zhao Min; Li Xu; Hanhui Chen; Xu Ding; Zhang Yi; Zhang Mingyuang
Journal:  Am J Drug Alcohol Abuse       Date:  2011-03-28       Impact factor: 3.829

4.  The Relationship between Different Amounts of Physical Exercise, Internal Inhibition, and Drug Craving in Individuals with Substance-Use Disorders.

Authors:  Tingran Zhang; Kun Wang; Ning Li; Chansol Hurr; Jiong Luo
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.